InsiderTrades.com logo
War on Elon Escalates…
From Porter & Company   |   Ad
Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
Click here to learn how you can benefit from its widespread distribution.

RYZB Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

RayzeBio Insider Trading History Chart

This chart shows the insider buying and selling history at RayzeBio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

RayzeBio Share Price & Price History

Current Price: $62.49
Price Change: +0.30 (1.20%)
As of 02/26/2024 01:00 AM ET

This chart shows the closing price history over time for RYZB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

RayzeBio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2023Global Investors Lp VikingMajor ShareholderBuy1,388,889$18.00$25,000,002.004,899,144View SEC Filing Icon  
9/19/2023Maha KatabiDirectorBuy472,222$18.00$8,499,996.001,209,764View SEC Filing Icon  
See Full Table
WARNING: “Buffett Indicator” flashing for first time in 50 years
From Behind the Markets   |   Ad
The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.
Take these 4 steps today to protect your retirement NOW

SEC Filings (Institutional Ownership Changes) for RayzeBio (NASDAQ:RYZB)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RYZB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

RayzeBio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/5/2024Wellington Management Group LLP3,504,409$215.91M0.0%-9.6%5.848%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC744,056$46.26M1.0%-4.2%1.242%Search for SEC Filing on Google Icon
2/15/2024Blackstone Inc.108,090$6.72M0.0%+8.1%0.180%Search for SEC Filing on Google Icon
2/14/2024Hhlr Advisors LTD.1,062,383$66.05M1.3%-23.9%1.773%Search for SEC Filing on Google Icon
2/14/2024Commodore Capital LP383,638$23.85M2.1%+32.8%0.640%Search for SEC Filing on Google Icon
2/14/2024PenderFund Capital Management Ltd.1,800$0.11M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/14/2024Harvest Management LLC50,000$3.11M2.9%N/A0.083%Search for SEC Filing on Google Icon
2/14/2024Water Island Capital LLC225,565$14.02M1.4%N/A0.376%Search for SEC Filing on Google Icon
2/13/2024GABELLI & Co INVESTMENT ADVISERS INC.38,850$2.42M0.5%N/A0.065%Search for SEC Filing on Google Icon
2/13/2024Gabelli Funds LLC52,600$3.27M0.0%N/A0.088%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 826$51K0.0%+403.7%0.001%Search for SEC Filing on Google Icon
2/13/2024Capital Research Global Investors170,808$10.62M0.0%-86.3%0.285%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.511,401$31.79M0.0%-38.6%0.853%Search for SEC Filing on Google Icon
2/7/2024Versor Investments LP80,771$5.02M1.0%N/A0.135%Search for SEC Filing on Google Icon
2/7/2024Alpine Associates Management Inc.762,900$47.43M2.4%N/A1.273%Search for SEC Filing on Google Icon
2/7/2024Kellner Capital LLC12,200$0.76M1.4%N/A0.020%Search for SEC Filing on Google Icon
2/7/2024Vivo Capital LLC110,581$6.88M0.6%-82.5%0.185%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.147,140$9.15M0.0%N/A0.246%Search for SEC Filing on Google Icon
2/6/2024BCK Capital Management LP15,000$0.93M0.9%N/A0.025%Search for SEC Filing on Google Icon
2/6/2024M&T Bank Corp7,480$0.47M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank2,347$0.15M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.4,055$0.25M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/1/2024Wolverine Asset Management LLC11,700$0.73M0.0%N/A0.020%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund8,969$0.56M0.0%+796.9%0.015%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio4,300$0.27M0.0%N/A0.007%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC8,138$0.51M0.0%N/A0.014%Search for SEC Filing on Google Icon
12/13/2023Teachers Retirement System of The State of Kentucky19,131$0.43M0.0%N/A0.032%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.24,907$0.55M0.0%N/A0.042%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP3,876,186$84.49M0.0%N/A6.469%Search for SEC Filing on Google Icon
11/15/2023RTW Investments LP46,300$1.03M0.0%N/A0.080%Search for SEC Filing on Google Icon
11/15/2023Redmile Group LLC1,857,706$41.24M2.0%N/A3.192%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP971,913$21.58M0.1%N/A1.670%Search for SEC Filing on Google Icon
11/15/2023Acuta Capital Partners LLC344,571$7.65M5.1%N/A0.592%Search for SEC Filing on Google Icon
11/14/2023venBio Partners LLC5,158,162$114.51M32.5%N/A8.864%Search for SEC Filing on Google Icon
11/14/2023Braidwell LP277,778$6.17M0.2%N/A0.477%Search for SEC Filing on Google Icon
11/14/2023Blackstone Inc.100,000$2.22M0.0%N/A0.172%Search for SEC Filing on Google Icon
11/14/2023Soros Fund Management LLC20,000$0.44M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/14/2023Deerfield Management Company L.P. Series C1,159,126$25.73M0.6%N/A1.992%Search for SEC Filing on Google Icon
11/14/2023Avidity Partners Management LP500,000$11.10M0.4%N/A0.859%Search for SEC Filing on Google Icon
11/14/2023Monashee Investment Management LLC27,500$0.61M0.3%N/A0.047%Search for SEC Filing on Google Icon
11/13/2023FMR LLC1,138,972$25.29M0.0%N/A1.957%Search for SEC Filing on Google Icon
11/13/2023Maven Securities LTD59,835$1.33M0.0%N/A0.103%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.24,907$0.55M0.0%N/A0.043%Search for SEC Filing on Google Icon
11/8/2023Vivo Capital LLC633,576$14.07M1.7%N/A1.089%Search for SEC Filing on Google Icon
11/3/2023Versant Venture Management LLC5,158,161$114.51M61.0%N/A8.864%Search for SEC Filing on Google Icon
11/3/2023Platinum Investment Management Ltd.222,222$4.93M0.2%N/A0.382%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc72,610$1.61M0.0%N/A0.125%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
RayzeBio logo
RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company's lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California. As of February 26, 2024, RayzeBio, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
Read More on RayzeBio

Today's Range

Now: $62.49
Low: $62.49
High: $62.49

50 Day Range

MA: $62.47
Low: $62.27
High: $62.49

52 Week Range

Now: $62.49
Low: $17.95
High: $62.51

Volume

N/A

Average Volume

553,592 shs

Market Capitalization

$3.74 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of RayzeBio?

RayzeBio's top insider shareholders include:
  1. Global Investors Lp Viking (Major Shareholder)
  2. Maha Katabi (Director)
Learn More about top insider investors at RayzeBio.
War on Elon Escalates…
From Porter & Company   |   Ad
Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
Click here to learn how you can benefit from its widespread distribution.